Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Farxiga (SGLT2i) approved for heart failure

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Farxiga (SGLT2i) approved for heart failure

barsax

May 06, 2020 08:53AM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Farxiga (SGLT2i) approved for heart failure

in response to

Farxiga (SGLT2i) approved for heart failure

barsax

posted on May 06, 2020 10:08AM

"AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction (HFrEF) with and without type-2 diabetes (T2D)." ( bolding added)

Is ABL just as effective in patients without type-2 diabetes as it is with, as found in the BOM trial?